Firefly BioWorks (Abcam)
Firefly BioWorks introduced an open platform that will allow industrial, academic, and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation.
Their mission was to develop reliable and affordable solutions for the comprehensive monitoring of biological function. In January 2015, Firefly BioWorks was acquired by Abcam.
Rapid multiplexed analysis for molecular diagnostics
This company was a spinout of the 2007 project, Rapid multiplexed analysis for molecular diagnostics.
MicroRNA detection on the cheap
MIT alumni’s startup provides rapid, cost-effective microRNA profiling, which is beneficial for diagnosing diseases.